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Cardiorespiratory fitness (CRF), as measured directly using respiratory gases, is the most accurate 
indicator of the ability to transport oxygen from the lung to the mitochondria to perform physical 
exercise. Left ventricular stroke volume, exercise heart rate, and arteriovenous oxygen differences at 
exercise are major determinants of CRF levels. Directly measured oxygen uptake (VO2), an objective 
and quantitative measure of CRF, is the gold standard for assessing the amount of oxygen 
consumption during exercise (1). It has been suggested that about half of the variance in CRF is 
attributable to heritable factors (2). CRF is significantly correlated with measures of pulmonary, 
cardiovascular, skeletal muscle, and metabolic function.  
Large clinical studies have shown the importance of an easily available submaximal testing for CRF 
assessment, which has relatively good reliability and validity (1). The use of CRF as a determinant 
of cardiac risk, specifically as a predictor of major cardiovascular (CVD) outcomes, has remained 
underused in clinical practice, e.g. due to proficiency constraints and the lack of very sophisticated 
equipment. Submaximal exercise test with the use of heart rate assessment is relatively easy to 
implement in clinics. However, consideration needs to be given for the fact that prevalent medical 
conditions, medication use (especially β-blockers), body size and severity of cardiac symptoms may 
have an effect on exercise-based heart rate response, which is commonly used in formulae to estimate 
CRF levels. Submaximal exercise testing can be an appropriate modality for patients with coronary 
heart disease (CHD) to assess CRF when a cardiopulmonary exercise test is not available or when 
resources are limited (3). In our previous studies, CRF (measured using peak oxygen uptake, VO2peak) 
was demonstrated to be inversely and independently associated with a lower risk of cardiovascular 
events, although VO2peak yielded only a modest improvement in sudden cardiac death risk prediction 
on the top of cardiovascular risk factors (4-6). Good CRF is also associated with attenuated coronary 
calcification and increased plaque stabilization, potentially reducing the risk of unexpected coronary 
events due to plaque rupture (7). The observed association on CRF and all-cause mortality has 
persisted across the lifespan (4). 
Given that normal reference standards for VO2peak are controversial because they tend to be 
population and protocol specific and need to be accurately interpreted with respect to age, gender and 
body weight, the use of VO2peak relative to an age and gender predicted value ie. percent-predicted 
VO2peak has been recommended. To date, there are only few published reports on the prognostic 
utility of percent-predicted VO2peak in patients with pre-existing cardiac disease. Furthermore, it is 
unknown whether analyses using only single baseline measurements of percent-predicted VO2peak 
would underestimate associations with outcomes. Due to measurement errors, lifestyle changes, aging 
and chronic diseases, assessments using baseline measurements of an exposure could underestimate 
the true strength of an association between an exposure and disease outcome in long-term cohort 
studies due to the phenomenon of regression of dilution bias (8). Our substudies on repeat assessments 
of CRF measurements within the Kuopio Ischemic Heart Disease prospective study show a within-
person variability in CRF levels measured many years apart (regression dilution ratio=0.58) (9). In 
the current issue of the International Journal of Cardiology, Chiaranda and colleagues evaluated the 
association between percent-predicted VO2peak and all-cause hospital readmission in 1283 male 
patients with stable CHD recruited into the Fitness Registry and the Importance of Exercise National 
Data Base (FRIEND) (10). To account for regression dilution bias, the authors also assessed whether 
serial changes in percent-predicted VO2peak were associated with new readmissions. For the 
estimation of CRF (measured by VO2peak), patients were instructed to keep a moderate pace for 10 to 
20 minutes using a 1km treadmill-walking test. VO2peak was estimated using an algorithm that 
included age, height, weight, time to walk 1000 m and heart rate (10). The percent-predicted VO2peak 
was derived from the FRIEND equation (henceforth referred to as FRIEND%PRED) (3). 
Rates of readmission were significantly lower across tertiles of improved FRIEND%PRED and persisted 
after adjustment for relevant confounders, including the use of β-blockers and diuretics (10). An 
important clinical finding was that the total hospital days were 2.0 and 3.2 times higher among 
patients with low and intermediate FRIEND%PRED levels compared to subjects in the highest CRF 
tertile. The authors also showed a strong inverse association between improvement in FRIEND%PRE 
and all-cause readmission rates. Cardiac patients with the highest increases in FRIEND%PRE had 
significantly lower readmission rates observed during the longer-term of follow-up. The current 
findings are relevant especially for healthcare systems and clinicians who have to consider 
appropriate use of resources. There were a number of drawbacks to this study which merit 
consideration, though the majority were acknowledged and discussed by the authors. Of much 
importance is the observation that the authors did not conduct formal risk prediction analyses to assess 
the prognostic relevance of FRIEND%PRE when added on top of risk factors for hospitalization, using 
measures of discrimination (eg, Harrell’s C-index) and reclassification (eg, net-reclassification-
improvement). CRF is a clinically useful indicator of the effectiveness of exercise-based 
rehabilitation. After an acute cardiac event, CRF levels may be partly explained by the timing of 
participation in cardiac rehabilitation programs and exercise testing. Secondly, the assessment of 
predicted CRF by using a submaximal test with heart rate is dependent on the population to be tested, 
and the use of medication such as β-blockers; data on cardiovascular interventions or other causes of 
hospitalization were not available in the current study. Furthermore, the percentages of patients taking 
aspirin and statins three years after baseline were not optimal.  
Considering the observational nature of the study, a causal association cannot be implied between 
low CRF and hospital readmissions. Nevertheless, the efforts of the authors must be applauded, 
having shown that CRF as a percentage of an age-specific value using the FRIEND equation 
(estimated using a simple walking test) may be a risk indicator for hospitalization rates in outpatients 
with CHD. To conclude, the authors’ suggestions on age-predicted VO2peak being a predictor of 
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